Corvus Announces Presentation of Preclinical Data on CPI-818, a First-in-class Covalent Inhibitor of ITK Targeting T-Cell Lymphomas Life Science Investing
miRagen Announces New Clinical Data in Patients With Three Different Types of Blood Cancers Treated With Cobomarsen Pharmaceutical Investing
PreveCeutical Provides Update on Research Program for Development of Non-Addictive Analgesics Cannabis Investing News
Nabriva Therapeutics Announces Acceptance of the New Drug Application for Intravenous CONTEPO Pharmaceutical Investing
Reata Announces Clinical Trial Design for FALCON a Phase 3 Trial of Bardoxolone Methyl Pharmaceutical Investing
